Literature DB >> 2139593

Tolerance of the hypertrophic heart to ischemia. Studies in compensated and failing dog hearts with pressure overload hypertrophy.

W H Gaasch1, M R Zile, P K Hoshino, E O Weinberg, D R Rhodes, C S Apstein.   

Abstract

Tolerance of the canine heart to prolonged ischemic arrest was studied in 10 hearts from normal control dogs and 15 hearts from dogs with left ventricular hypertrophy (LVH); experiments were performed 1 year after banding the aorta in 8-week-old puppies. At 1 year, hemodynamic studies revealed decreased left ventricular (LV) fiber shortening and elevated end-diastolic pressure (EDP) in five dogs (group with LVH failure); 10 dogs exhibited normal shortening and normal EDP (group with LVH compensation). The left ventricle-to-body weight ratio (g/kg) was 4.4 +/- 0.8 in the control group of dogs, 7.7 +/- 1.0 in the group with LVH compensation, and 10 +/- 2.5 in the group with LVH failure. The tolerance to 60 minutes of global ischemia (37 degrees C) followed by 90 minutes of reperfusion was studied in an isolated blood-perfused heart apparatus (isovolumic left ventricle, coronary perfusion pressure of 100 mm Hg). In the baseline (preischemic) state, coronary blood flow, myocardial oxygen consumption, lactate extraction, and myocardial high-energy phosphate content were essentially equal in the three groups; with LV volume adjusted to produce a systolic pressure of 100 mm Hg, there were no significant differences in LVEDP among the three groups. During ischemia, the diastolic (asystolic) pressure increased from 11 +/- 3 to 28 +/- 16 mm Hg (p less than 0.05) in the group with LVH failure; however, it did not increase in the control or the LVH compensation groups. Myocardial ATP levels declined equally in all three groups. During early reperfusion, lactate washout was lowest in the group with LVH failure. By 90 minutes of reperfusion, there were no significant differences in coronary blood flow, myocardial oxygen consumption, lactate extraction, or high-energy phosphate levels. High diastolic pressure persisted at 90 minutes of reperfusion in the LVH failure group (EDP was 34 +/- 19 mm Hg); however, there was no significant change in EDP during reperfusion in the control or with LVH compensation groups. After 90 minutes of reperfusion, developed pressures in the control (54 +/- 9 mm Hg), the LVH compensation (49 +/- 18 mm Hg), and the LVH failure (67 +/- 17 mm Hg) groups were not significantly different. These data indicate that hearts with compensated LVH do not exhibit an impaired tolerance to ischemia.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139593     DOI: 10.1161/01.cir.81.5.1644

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy.

Authors:  Heberty T Facundo; Robert E Brainard; Lewis J Watson; Gladys A Ngoh; Tariq Hamid; Sumanth D Prabhu; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-09       Impact factor: 4.733

2.  Differential effects of hypoxic and hyperoxic stress-induced hypertrophy in cultured chick fetal cardiac myocytes.

Authors:  Allison A Greco; George Gomez
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-29       Impact factor: 2.416

3.  Tolerance of myocardium of aged animals to repeated oxygen deficiency.

Authors:  H M Hoffmeister; L Seipel
Journal:  Basic Res Cardiol       Date:  1992 Mar-Apr       Impact factor: 17.165

Review 4.  Energy metabolism in the hypertrophied heart.

Authors:  Nandakumar Sambandam; Gary D Lopaschuk; Roger W Brownsey; Michael F Allard
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

5.  Impaired insulin-signaling in hypertrophied hearts contributes to ischemic injury.

Authors:  Ingeborg Friehs; Hung Cao-Danh; Meena Nathan; Francis X McGowan; Pedro J del Nido
Journal:  Biochem Biophys Res Commun       Date:  2005-05-27       Impact factor: 3.575

6.  Energy metabolism and mechanical recovery after cardioplegia in moderately hypertrophied rats.

Authors:  R T Smolenski; J Jayakumar; A M Seymour; M H Yacoub
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

Review 7.  AMPK alterations in cardiac physiology and pathology: enemy or ally?

Authors:  Jason R B Dyck; Gary D Lopaschuk
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

Review 8.  Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.

Authors:  Yan Burelle; Maya Khairallah; Alexis Ascah; Bruce G Allen; Christian F Deschepper; Basil J Petrof; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2009-09-18       Impact factor: 5.000

9.  Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis.

Authors:  Bradley K McConnell; Zoran Popovic; Niladri Mal; Kwangdeok Lee; James Bautista; Farhad Forudi; Raul Schwartzman; J-P Jin; Marc Penn; Meredith Bond
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

10.  Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.

Authors:  Rodrigo Barillas; Ingeborg Friehs; Hung Cao-Danh; Joseph F Martinez; Pedro J del Nido
Journal:  Ann Thorac Surg       Date:  2007-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.